For: | Liu T, Xie XL, Zhou X, Chen SX, Wang YJ, Shi LP, Chen SJ, Wang YJ, Wang SL, Zhang JN, Dou SY, Jiang XY, Cui RL, Jiang HQ. Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma. World J Gastroenterol 2021; 27(28): 4667-4686 [PMID: 34366628 DOI: 10.3748/wjg.v27.i28.4667] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i28/4667.htm |
Number | Citing Articles |
1 |
Hai-Yan Zhang, Jia-Jie Zhu, Zong-Ming Liu, Yu-Xuan Zhang, Jia-Jia Chen, Ke-Da Chen. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network. Hepatobiliary & Pancreatic Diseases International 2024; 23(3): 272 doi: 10.1016/j.hbpd.2023.06.009
|
2 |
Yuting Yin, Chun Wu, Yufeng Zhou, Meiyin Zhang, Shijuan Mai, Minshan Chen, Hui-Yun Wang. Ezetimibe Induces Paraptosis through Niemann–Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells. Genes 2023; 15(1): 4 doi: 10.3390/genes15010004
|
3 |
Rok Razpotnik, Robert Vidmar, Marko Fonović, Damjana Rozman, Tadeja Režen. Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma. Cancers 2022; 14(18): 4524 doi: 10.3390/cancers14184524
|
4 |
Jia‐heng Xing, Ru‐xue Tan, Fei‐er Huang, Nan Tian. Integrated analyses for identification of a three‐gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment. Journal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18211
|
5 |
Ganghui Ye. Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review). American Journal of Cancer Research 2024; 14(9): 4113 doi: 10.62347/UJVP4361
|
6 |
Yanfeng Wang, Yuhan Cao, Yingcong Wang, Junwei Sun, Lidong Wang, Xin Song, Xueke Zhao. Construction and analysis of protein-protein interaction network for esophageal squamous cell carcinoma. Computers in Biology and Medicine 2024; 182: 109156 doi: 10.1016/j.compbiomed.2024.109156
|
7 |
Ting Liu, Congjie Zhai, Bo Tian, Chao Li, Shuangshuang Han, Shihui Wang, Mingda Xuan, Dehua Liu, Yunxia Zhao, Hongyan Zhao, Weifang Yu, Jia Wang. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53013-3
|
8 |
Xiaodong Li, Xuedong Yin, Heyi Bao, Chang Liu. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway. Molecular and Cellular Probes 2023; 67: 101877 doi: 10.1016/j.mcp.2022.101877
|
9 |
Xiaoju Huang, Mengmeng Wang, Dan Zhang, Junpeng Meng, Pian Liu. ZDHHC20 Activates AKT Signaling Pathway to Promote Cell Proliferation in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 1763 doi: 10.2147/JHC.S457682
|
10 |
Chenglian Hu, Ying Yang, Lun Ye. miR-10a Ameliorates Renal and Myocardial Injury in Sepsis Through Regulation of PI3K/AKT Signaling. Journal of Biomaterials and Tissue Engineering 2023; 13(2): 301 doi: 10.1166/jbt.2023.3255
|